Welcome Back
Click “Sign in” to agree to Cointime’s Terms of Service and acknowledge that Cointime’s Privacy Policy applies to you.
Join CoinTime
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">Terms of Service</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">Privacy Policy</a> applies to you.
Sign in with email
Sign up with email
Your email
Check your inbox
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Amphista Therapeutics
company
About
Amphista Therapeutics operates as a biopharmaceutical company.
- Motherwell,North Lanarkshire,United Kingdom
- 51 - 100
- https://www.amphista.com/
Details
- Last Funding Type
- Series B
- Industries
- Biopharma,Biotechnology
- Founded date
- Jan 1, 2017
- Number Of Employee
- 51 - 100
- Operating Status
- Active
Amphista Therapeutics operates as a biopharmaceutical company creating first-in-class cancer therapeutics that harness the body's natural processes to selectively and efficiently degrade and remove disease causing proteins.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
$60.50M
Amphista Therapeutics has raised a total of
$60.50M
in funding over 2 rounds. Their latest funding was raised on
Dec 13, 2022 from a Series B round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Dec 13, 2022 | Series B | — | 1 |
Dementia Discovery Fund
|
— | Detail |
| Mar 17, 2021 | Series B | $53M | 6 |
Forbion Capital Partners
|
— | Detail |
| Apr 7, 2020 | Series A | $7.50M | 4 |
Advent Life Sciences
|
— | Detail |
Investors
Number of Lead Investors
Number of Investors
4
9
Amphista Therapeutics is funded by 9 investors.
Dementia Discovery Fund
and Forbion Capital Partners
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
|
Dementia Discovery Fund
|
Yes | Series B |
|
Forbion Capital Partners
|
Yes | Series B |
|
|
Yes | Series B |
|
Advent Life Sciences
|
— | Series B |
BioMotiv
|
— | Series B |
Eli Lilly & Company Foundation
|
— | Series B |
Novartis Venture Fund
|
— | Series B |
European Investment Fund
|
— | Series A |
Scottish Investment Bank
|
— | Series A |
Employee Profiles
Number of Employee Profiles
6
Amphista Therapeutics has 6 current employee profiles, including
Executive Alessio Ciulli
Executive
Executive
Executive
Board member
Executive
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
